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Abstract
The purpose of this study was to describe private insurance reimbursements for newborn hearing screening (NBHS) in
the United States. Data from the MarketScan® Commercial Databases were used to estimate itemized reimbursements
for privately insured infants born between January 1, 2013–December 31, 2014. Estimates were based on billed claims
for hearing screening services during infancy among 456,407 infants with birth hospitalization claims (71,820 infants with
inpatient NBHS and 1,104 infants with outpatient NBHS). The median reimbursement for NBHS was almost three times
greater when performed in an inpatient setting than outpatient setting. Median reimbursement for NBHS performed in a
hospital and billed as inpatient service was $148.00 (interquartile range [IQR] $99.52–$210.00) and $57.53 (IQR $34.40–
$120.91) when billed as an outpatient service. The mean reimbursement for NBHS performed in an outpatient hospital
setting was $136.48 (IQR $86.08–$220.15) and $41.60 (IQR $28.15–$57.52) for NBHS billed in conjunction with an
office visit (e.g., performed in an audiology clinic, an audiologist’s office, or physician’s office during a routine check-up).
No NBHS claims were filed for 84.3% of infants (384,587/456,407), as NBHS is generally included as a covered service
bundled along with delivery and newborn care.
Acronyms: ABR = auditory brainstem response; CPT = current procedural terminology, ICD-9-CM = International
Classification of Diseases, Ninth Revision, Clinical Modification; IQR = interquartile range; NBHS = newborn hearing
screening; OAE = otoacoustic emissions
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Almost all infants in the United States are screened soon
after birth for hearing loss using automated auditory
brainstem response (automated ABR) and/or otoacoustic
emissions (OAE). Both OAE and automated ABR tests
provide non-invasive recordings of physiologic activity
underlying normal auditory function for the purpose of
confirming the presence or absence of a hearing loss
(Wroblewska-Seniuk, Dabrowski, Szyfter, & Mazela,
2017). These reliable and objective methods of testing
and screening can be easily performed in newborns and
infants, either used alone or in sequence (Joint Committee
on Infant Health [JCIH], 2007; Wroblewska-Seniuk et al.,
2017).
Little is known about the healthcare cost of newborn
hearing screening in the United States. Estimates of the
resource cost of hospital-based NBHS in terms of staff
time, instruments, and consumables in U.S. hospitals
published between 1995 and 2002 ranged from $25 to
$50 per infant screened, adjusted for inflation to 2016
U.S. dollars, but more current estimates are lacking
(Grosse, Mason, Gaffney, Thomson, & White, 2018). In
any case, there may be little relation between resource

costs, charges, and reimbursements for hospital services.
When NBHS is conducted by hospital staff, there is usually
no separate bill and it is bundled in the overall labor
and delivery charge (Winston-Gerson & Rousch, 2016).
Some hospitals outsource hearing screening services to
a contractor, who can bill families and insurers separately.
Based on anecdotal parent reports, Winston-Gerson and
Rousch (2016) reported a typical charge for NBHS by a
contractor is $250 and could be in excess of $500.
An analysis of 2004 insurance claims data reported the
average private-sector payer cost of screening for hearing
loss in the hospital was $84 (95% confidence interval
[CI]: $0–$200) when billed and paid separately from the
labor and delivery charge (Grosse, 2006). McManus
et al. (2010) reported proprietary estimates of typical
direct provider payments by an employer health plan in
2005 was $82.01 for an OAE test with limited evaluation
(current procedural terminology [CPT] code 92587) for
the sole purpose of confirming the presence or absence
of a hearing loss (McManus et al., 2010). The authors
of that study did not include the other OAE screening
CPT code (92558) in their estimates. The purpose of this
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analysis was to provide more up-to-date information on
reimbursement rates for privately insured infants who are
individually billed for NBHS during infancy in both inpatient
and outpatient settings.
Method
Data Source
This retrospective analysis used claims data from the
IBM® MarketScan® Commercial Research Databases
from 2013 through 2015. The commercial databases
include employer-sponsored insurance claims data for
approximately 30 to 40 million employees and their
beneficiaries each year from all U.S. states. The databases
contain fully integrated, de-identified, individual-level
data across the entire continuum of care (e.g., inpatient,
outpatient, outpatient pharmacy, laboratory) that capture
real-world treatment patterns and expenditures (Truven
Health Analytics, 2017). Each enrollee is assigned a deidentified unique number, allowing linkage across claims
over time. MarketScan data is de-identified and their
analysis is not classified by the Centers for Disease Control
and Prevention as human subjects research and has been
determined not to require an Institutional Review Board.
Claims were identified using the International Classification
of Diseases, Ninth Revision, Clinical Modification (ICD9-CM) codes (Table 1). Inpatient and outpatient data

were extracted from MarketScan Research Databases
(2013–2015) for infants born between January 1, 2013
and December 31, 2014, who were individually billed
for NBHS, did not die during the study period, and had
a first claim with a delivery code. The analysis included
the following information: birth year, gender of patient
(male/female), setting (inpatient/outpatient), outpatient
place of service, census division, diagnoses, procedures,
service date, procedure age (days), net payment, and
health plan type. An algorithm (Figure 1 and Table 1) was
used to create a proxy birth date using the admission
date of the first inpatient claim for the baby containing a
delivery code (ICD-9-CM: V30-31, V33-V34, V36-V37,
and V39). We analyzed three CPT codes typically used
for hearing screening (American Academy of Pediatrics,
2016): 92586 (automated ABR), 92558 (screening OAE),
and 92587 (distortion product evoked OAE or OAE with
limited evaluation). See Table 1 for detailed descriptions.
OAE comprehensive diagnostic evaluation code 92588,
used to bill for a test to determine the amplitude level of
an otoacoustic emission output at each discrete frequency
and not to determine the presence or absence of a hearing
loss, was not examined. Service date was the date when
the procedure or service occurred.

Table 1
List of Newborn Birth and Hearing Screening Codes Inpatient ClaimsInpatient Claims
Code(s)

Newborn ICD-9-CM
Delivery Codes

V30-31, V33-V34,
V36-V37, V39

Newborn Hearing
Screening CPT Codes

Code Description

Live birth

Born in 2013-2014
N = 456,407 infants

Born in 2013-2014
N = 456,407 infants

Proxy birth date or enrollment
ProxyID
birth date or enrollment ID
N = 443,283 infants
N = 443,283 infants

Alive at discharge with birth
Alive
date
at discharge with birth date
N = 442,843 infants
N = 442,843 infants

Outpatient Claims
Outpatient Cl

Starting Sample Matched Starting Sample Mat
Inpatient IDs
Inpatient IDs
N = 88,681 infants
N = 88,681 infan

Billing codes for
NBHS* and known
place of service
N = 1,208 infants

Billing codes fo
NBHS* and know
place of service
N = 1,208 infant

Cost ≥ $1
N = 1,104 infants

Cost ≥ $1
N = 1,104 infant

Claim ≥ 1 day apart

Claim ≥ 1 day apa

92586 Automated ABR

Auditory evoked potentials for
Billing codes for NBHS and
Billing codes for NBHS and
evoked response audiometry
known place of service
known place of service
and/or testing of the central N = 107,187 infants
N = 107,187 infants
nervous system; limited

92558 Screening OAE

N = 1,104 infants
N = 1,104 infant
Evoked otoacoustic emissions,
Cost ≥ $1
Cost ≥ $1
screening; qualitative
N = 90,517 infants
measurement of distortion N = 90,517 infants
product or transient evoked
*Billing codes for new born hearing
screening (NBHS) include Current
Had both screening and delivery
otoacoustic emissions, Had both screening and delivery
*Billing codes for newborn hearing
*Billingscreening
codescodes:
for (NBHS)
newborninclude
hearing screening
Procedures Terminology
code
code
automated analysis
Current Procedures Terminology
Current
codes:
Procedures
92558, Terminology
92586, and 92587.
codes: 9255
92558, 92586, and 92587.
N = 71,820 infants

92587 OAE Limited
Evaluation

Distortion product evoked
otoacoustic emissions; limited
evaluation (to confirm the
presence or absence of hearing
disorder, 3–6 frequencies) or
transient evoked otoacoustic
emissions, with interpretation
and report

Note. ABR = automated auditory brainstem response; CPT =
current procedural terminology codes; ICD-9-CM = International
Classification of Diseases, 9th Revision, Clinical Modification;
OAE = otoacoustic emissions.

N = 71,820 infants

Figure 1. Flowchart depicting the selection process of
inpatient (left) and outpatient claims (right) included in the
present study. CPT = current procedural terminology.
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Procedure age (days) was estimated using the difference
between service date and proxy birth date. Net payment is
defined as the payment received by the provider, excluding
patient out-of-pocket and coordination of benefits. Claims
were categorized as inpatient or outpatient using the place
of service code. For inpatient claims, the place of service
codes included inpatient hospital, hospital emergency
room, and birthing center. Inpatient claims represent billing
as occurring in the hospital inpatient setting when a patient
was admitted into the hospital and a service was provided
during the hospital stay. The outpatient place of service
codes included outpatient hospital and office. Outpatient
services can occur after an infant has been discharged
from a hospital or birthing center. In the case of NBHS,
the outpatient service can be a repeat or an initial screen.
When place of service is coded as an office visit, the
service can occur in an audiology clinic, an audiologist’s
office, or a physician’s office during a routine well child
visit. When the place of service is coded as outpatient
hospital, the infant is receiving the service as an outpatient
at a hospital-owned facility. Claims were categorized as
nine census divisions defined by the U.S. Census Bureau
(New England, Middle and South Atlantic, East and West
North Central, East and West South Central, Mountain,
and Pacific), and unknown region.
Data Analysis
In this descriptive analysis, all claims for services that an
individual received on a given service date are assumed
to refer to a single encounter. The proxy birth date was
used to limit claims to the first year of life (infancy), that is,
difference in days between service date and birth date (<
365 days). Mean, median, range, and interquartile range
(IQR) of the net payments were calculated by summing
each claim. Medical expenditures were adjusted for
inflation to 2014 dollars and reported by care setting and
place of service.
Claims were excluded if (a) enrollment ID was missing; (b)
the infant died before discharge; (c) the difference between
the service date and proxy birth date was a negative
number (i.e., screening occurred before proxy birth date in
which proxy birth date could not be determined); (d) infant
was not individually billed for NBHS or place of service
was unspecified; and (e) sum of the net payment for a
single encounter was equal to or less than $1 irrespective
if the claim was denied or reimbursed. Claims presumed to
be duplicates of the initial claim were also excluded (claims
with similar dates and billing codes). Inpatient claims
were limited to those occurring during birth hospitalization
(containing both NBHS and delivery codes). All analyses
were conducted using SAS software version 9.4 (SAS
Institute Inc., Cary, NC). Descriptive statistics (frequency
counts and percentages) were used to compare mean
and median reimbursement rates and IQRs by setting
(inpatient/outpatient), outpatient place of service, and
census division.

for NBHS. Of those infants, 1,104 (1.5%) also had
outpatient claims for NBHS (Table 2 and Figure 1).
Mean reimbursement rates for NBHS were higher than
the median reimbursement rates (Table 2). Median
reimbursement for NBHS (IQR) performed in a hospital
setting was $148.00 ($99.52–$210.00) billed as an
inpatient service, and $57.53 ($34.40–$120.91) billed
as an outpatient service. The median reimbursement
for NBHS (IQR) was $136.48 ($86.08–$220.15) for an
outpatient service in a hospital facility and $41.60 ($28.15–
$57.52) for NBHS billed in conjunction with an office visit
(Table 2).

Table 2
Descriptive Summary of Individually Billed Newborn
Hearing Screening Claims for Infants Born 2013–2014
Newborn Hearing Screening
Variable

Inpatient

Outpatient

n (%)

n (%)

Total Claims

72,146

1,300

Total Enrollees

71,820

1,104

1.0 (1.0–1.0)

1.2 (1.0–4.0)

Mean Net Payment
(Range)

$159.46
($1.04–$1580.10)

$96.89
($2.03–$1320.78)

Median Net
Payment (IQR)

$148.00
($99.52–$210.00)

$57.53
($34.40–$120.91)

Office

N/A

$50.68
($4.11–$714.00)

Outpatient Hospital

N/A

$169.87
($2.03–$1320.78)

Office

N/A

$41.60
($28.15–$57.52)

Outpatient Hospital

N/A

$136.48
($86.08–$220.15)

Male

37,403 (52.1)

608 (55.1)

Female

34,417 (47.9)

496 (44.9)

Mean number of
Claims (Range)

Net Payment
Reimbursements

Mean Net Payment
for Outpatient Place
of Service (Range)

Median Net Payment
for Outpatient Place
of Service (IQR)

Gender of Patient

Note. IQR = Interquartile Range.

Results
Among 456,407 privately insured infants born during
2013–2014, 71,820 (15.7%) had inpatient claims
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Reimbursement rates for NBHS varied significantly by
procedure and setting (Table 3). For inpatient NBHS
and outpatient office visit NBHS, mean and median
reimbursements for automated ABR (CPT 92586) were
substantially higher than OAE hearing screening (CPT
92558 or 92587). The same was true for outpatient
hospital-based claims, with reimbursements for automated
ABR (CPT 92586) slightly higher than for OAE hearing
screening (CPT 92558 or 92587). About half of the
inpatient claims for NBHS (49.4%, 249/504) were for
automated ABR. Most of outpatient claims for NBHS
(94.2%, 750/796) were for OAE hearing screening
services. The median reimbursement (IQR) for automated
ABR was $150.00 ($104.40–$210.68) when billed as an
inpatient screen, $102.18 ($75.81–$169.13) as an office
hearing screen, and $164.34 ($94.02–$254.00) as an

outpatient hospital screen. The median reimbursement
(IQR) for screening OAE tests (CPT 92558) or OAE with
limited evaluation (CPT 92587) was $57.80 ($29.37–
$108.68) when billed as an inpatient service, $39.74
($27.63–$52.54) as an office screening service, and
$116.90 ($78.22–$178.27) as a hospital outpatient service.
In the outpatient setting, reimbursement rates were higher
for OAE hearing screening (CPT 92558 or 92587) and
automated ABR (CPT 92586) occurring as an outpatient
hospital visit than an office visit, where hearing screens
were performed in an audiology clinic, an audiologist’s
office, or a physician’s office (Table 3). Irrespective of
outpatient place of service, reimbursement for automated
ABR (CPT 92586) was higher than OAE hearing screening
(CPT 92558 or 92587).

Table 3
Unweighted Inpatient and Outpatient Hearing Screening Reimbursement Rates* for Newborns Born between 2013 and 2014
Inpatient Hearing Screen (n = 72,176 claims)
CPT Codes

92558 or 92587 OAE
92558 only
92587 only

92586 Automated ABR

n (%)

Mean (Range)

2,228 (3.1)

$73.38 ($2.25–$1121.48)

66 (0.1)

$63.86 ($8.40–$293.61)

2,162 (3.0)

$73.67 ($2.25–$1121.48)

69,948 (96.9)

$162.20 ($1.04–$1580.10)

Median (IQR)

$57.80 ($29.37–$108.68)
$60.35 ($21.92–$95.85)

$57.14 ($29.65–$109.24)

$150.00 ($104.40–$210.68)

Outpatient Newborn Hearing Screen (n = 1,300 claims)
CPT Codes

n (%)

Mean (Range)

Median (IQR)

255 (19.6)

$45.42 ($4.11–$360.00)

$39.74 ($27.63–$52.54)

Office
92558 or 92587
92586

249 (19.2)

$136.33 ($31.71–$714.00)

$102.18 ($75.81–$169.13)

750 (57.7)

$155.98 ($2.03–$1320.78)

$116.90 ($78.22–$178.27)

Outpatient Hospital
92558 or 92587
92586

46 (3.5)

$184.09 ($2.43–$650.00)

$164.34 ($94.02–$254.00)

$41.98 ($6.85–$176.27)

$33.00 ($12.78–$60.00)

$176.65 ($2.43–$714.00)

$156.90 ($87.23–$250.00)

Irrespective of outpatient place of service
92558
92587
92586

39 (3.0)

966 (74.3)
295 (22.7)

$74.75 ($2.03–$1320.78)

$47.64 ($30.74–$83.98)

Note. CPT = Current Procedural Terminology; IQR = Interquartile Range.
*IBM® MarketScan® Commercial Databases for 2013–2015
As shown in Tables 4 and 5, the average reimbursement
rates varied by census division. For inpatient hearing
screens, the South Atlantic had the highest median
reimbursement rate and East South Central had the
lowest median reimbursement rate ($196.02, IQR
$98.74–$239.14 and $107.93, IQR $85.22–$160.00,
respectively; Table 4). For outpatient hearing screens, the
lowest median reimbursement rates ranged from $32.02
(IQR $24.00–$58.28) in the West South Central to the
highest $158.56 (IQR $57.52–$210.00) in the Pacific
(Table 5). The census division with the highest median

reimbursement for an outpatient service in a hospital
facility and office visit were Middle Atlantic ($195.57, IQR
$105.20–$254.00) and Pacific ($49.25, IQR $31.71–
$57.52; Table 5).
Discussion
Our estimates of average reimbursement for NBHS by
private insurers for screening conducted in birth hospitals
are substantially greater than published estimates of the
resource costs of providing such services. Published
U.S. cost estimates for pre-discharge hospital screening
have generally been in the range of $27 to $47 per infant
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Table 4
Summary of Inpatient Net Payment Reimbursement by Census Division*

Inpatient Newborn Hearing Screening (n = 72,146 claims)

No. of
Claims

Census Division

New England

Middle Atlantic

East North Central

West North Central
South Atlantic

East South Central

West South Central
Mountain
Pacific

Unknown Region

Mean (Range)

Median (IQR)

1,208

$175.11 ($2.57–$980.70)

$120.17 ($109.09–$215.10)

6,493

$177.17 ($2.52–$1106.50)

$144.00 ($109.60–$239.00)

6,680

$127.27 ($1.63–$840.00)

$116.00 ($104.21–$139.82)

2,377

$117.54 ($2.80–$714.00)

$113.51 ($90.00–$135.00)

9,735

$178.18 ($1.23–$1121.48)

$196.02 ($98.74–$239.14)

5,718

$123.99 ($1.41–$490.04)

$107.93 ($85.22–$160.00)

19,273

$185.79 ($1.15–$1580.10)

$185.00 ($148.00–$246.46)

12,506

$139.02 ($1.32–$478.00)

$136.18 ($90.19–$179.25)

7,505

$152.90 ($1.04–$576.78)

$143.40 ($81.42–$215.00)

681

$157.17 ($5.31–$714.00)

$148.00 ($104.49–$204.30)

Note. IQR = Interquartile Range.
* IBM® MarketScan® Commercial Databases for 2013–2015
Table 5
Summary of Outpatient Net Payment Reimbursement by Census Division*

Newborn Hearing Screening Outpatient (n = 1,300 claims)

All Outpatient Claims
No. of
Census Division Claims

Outpatient Mean
(Range)

Outpatient by Place of Service

Outpatient Median
(IQR)

Outpatient Hospital
Median (IQR)

Office Median
(IQR)

New England

25

$99.04 ($21.59–$482.11)

$66.40 ($40.23–$145.09)

$151.18 ($69.27–$164.21)

$40.23 ($40.23–$60.56)

Middle Atlantic

289

$100.92 ($2.43–$734.25)

$54.92 ($39.50–$121.50)

$195.57 ($105.20–$254.00)

$45.18 ($34.00–$54.92)

East North Central

95

$96.56 ($17.99–$1320.78)

$57.60 ($42.88–$93.33)

$102.66 ($81.48–$182.47)

$44.80 ($32.42–$57.60)

West North Central

26

$65.51 ($12.78–$176.27)

$47.37 ($39.65–$91.50)

$82.35 ($39.65–$105.00)

$45.00 ($21.00–$78.00)

South Atlantic

227

$113.32 ($4.11–$714.00)

$69.59 ($37.75–$140.18)

$169.06 ($93.25–$293.78)

$47.59 ($32.36–$81.23)

East South Central

92

$88.45 ($4.69–$640.80)

$51.82 ($33.90–$97.87)

$128.21 ($98.09–$287.66)

$38.57 ($33.90–$55.90)

West South Central

230

$62.04 ($4.43–$1122.66)

$32.02 ($24.00–$58.28)

$103.41 ($60.91–$182.59)

$30.48 ($21.34–$43.59)

Mountain

181

$78.67 ($2.03–$339.08)

$72.56 ($41.92–$106.77)

$94.02 ($72.56–$131.08)

$41.97 ($24.97–$61.10)

Pacific

126

$78.67 ($22.71–$550.00)

$158.56 ($57.52–$210.00)

$175.00 ($138.53–$281.86)

$49.25 ($31.71–$57.52)

Note. CPT = Current Procedural Terminology; IQR = Interquartile Range. Results for unknown region (n = 9) are not
shown because of small numbers.
*IBM® MarketScan® Commercial Databases for 2013-2015
screened, adjusted for inflation to 2016 U.S. dollars
(Grosse et al., 2018). In contrast, average inpatient NBHS
reimbursements reported here, with IQR from $100 to
$210 (Table 2), are several times as high.
Our retrospective analysis of the private insurance
reimbursements rate for NBHS services using IBM®
MarketScan® Commercial Research Databases
(2013–2015) complements previous analyses (Grosse,
2006; McManus et al., 2010). There are a limited
number of NBHS cost studies specifically looking at
the reimbursement rate using the procedure codes.
Whereas McManus et al. (2010) investigated the Medicaid

reimbursement rates for all types of hearing services
for infants and young children, our study provides
reimbursement estimates by setting and type of screening
services for privately insured infants. McManus et al.
(2010) reported mean Medicaid reimbursement rates of
$106.30 for automated ABR (CPT 92586) and $99.40
for OAE with limited evaluation (CPT 92587 adjusted
for inflation to 2014 dollars) irrespective of inpatient or
outpatient setting. Our mean estimates for automated ABR
(CPT 92586: $162.26, range $1.04–$1580.10) and OAE
with limited evaluation (CPT 92587: $74.00, range $2.03–
$1320.78) irrespective of inpatient or outpatient setting
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were higher for privately insured infants than for infants
with Medicaid (results not shown).
It should be emphasized that the vast majority (84.3%) of
privately insured infants who received a hospital-based
NBHS were not separately billed for the service because
the cost of providing a hearing screen for a newborn is
typically bundled under the newborn delivery care charge.
Consequently, the reimbursements reported here do
not characterize how much hospitals are reimbursed for
NBHS. The reimbursement rate reported here in most,
if not all, cases reflect reimbursements to independent
providers or contractors contracted to perform NBHS.
We were unable to find studies on the estimated resource
cost of conducting screening by an independent provider
or contractor contracted to perform NBHS. In contrast, we
found several older studies that have reported resource
cost estimates associated with NBHS conducted by
hospital staff (Kezirian, White, Yueh, & Sullivan, 2001;
Maxon, White, Behrens, & Vohr, 1995; Mehl & Thomson,
1998; Vohr et al., 2001). Kezirian et al. and Vohr et al.
estimates were based on direct cost of the equipment,
overhead, and all personnel cost including clerical
administrative assistance cost. Kezirian et al. reported
the cost of providing an OAE hearing screen was $13 per
infant and the cost for an automated ABR hearing screen
was $25 per infant. Vohr et al. reported $28.69 for an OAE
hearing screen and $32.81 for an automated ABR hearing
screen. Adjusting to 2014 dollars, the cost of providing an
OAE hearing screen would range from $17.38 to $38.25
and the cost of an automated ABR screen would range
from $33.42 to $43.86. These costs would not accurately
describe the cost for independent providers or contractors
contracted to perform NBHS. Since those cost estimates
are very old, it is not clear that adjustment for inflation is
sufficient. It would be helpful to have estimates from new
hearing screening cost studies.
Reimbursement rates appeared to be dependent on
the type of hearing screening service and place of
service. Unlike previous studies that reported only mean
reimbursements, this analysis provided means, medians,
range, and IQRs for reimbursements. The median, unlike
the mean, is not influenced by a small number of extremely
large or small values. Therefore, the median net payment
may provide a better estimate of the typical inpatient
reimbursement.
This study provides new cost information on how the two
screening methods were used across places of service,
OAE, and automated ABR. Almost half (49.4%) of privately
insured infants who were individually billed for NBHS as
an inpatient received an automated ABR screen, while
almost all (94.2%) infants who were individually billed for
outpatient NBHS received an OAE screen (Table 3). The
decision to use ABR screening equipment by a hospital for
inpatient screening could be driven by both best practice
considerations and the higher reimbursement rate relative
to OAE hearing screen. On average, the claim for an
automated ABR screen performed as an inpatient service
(median payment) was reimbursed 2.6 times higher than

for an OAE hearing screen performed in the same setting.
The ratio of reimbursements between the two types of
service was also the same for office visit claims, yet only
half of inpatient visit claims were for OAE.
We found the median net payment per claim for NBHS
was almost three times as high for inpatient as for
outpatient claims (Table 2). This appears to largely reflect
differences in the relative shares of automated ABR
and OAE screening types between inpatient and office
visits. Within those settings there were much smaller
differences in reimbursements by service type. In hospital
outpatient claims, reimbursements were similarly high
for both service types (Table 3). Separately reporting
outpatient and inpatient reimbursements provides a more
comprehensive and accurate summary of the variability in
reimbursement rates by type of service.
The higher average reimbursement for automated ABR
than OAE hearing screening services performed as an
inpatient service in the hospital is consistent with some
published estimates of resource costs (Kezirian et al.,
2001; Lin et al., 2005; Lin, Shu, Lee, Lin, & Lin, 2007).
Performing automated ABR requires the use of disposable
electrodes, which is not required for an OAE hearing
screening procedure. The electrode supply adds to the
total cost of providing an automated ABR hearing screen.
However, a few studies reported little cost difference
between automated ABR and OAE hearing screening
services (Lemons et al., 2002; Vohr et al., 2001).
The median and mean reimbursements for an automated
ABR screen performed for an outpatient hospital service,
$164.34 and $184.09, were higher than the reimbursement
rate in an office setting, $102.18 and $136.33, but similar
to the inpatient hospital reimbursement rate of $150.00
and $162.20. For OAE hearing screens, the median and
mean reimbursements were lower when conducted in
an office setting, $39.74 and $45.42, than in an inpatient
setting, $57.80 and $73.38. The highest reimbursement
rate for OAE screening service took place in a hospital
setting as an outpatient service, $116.90 and $155.98. In
the inpatient and outpatient settings, reimbursements were
lower for OAE than automated ABR hearing screen.
We were unable to find any previously published cost
study specifically looking at the cost of providing hearing
screening in an office as the place of service after infants
have been discharged from the hospital. We were able
to find the cost for providing post-discharge hearing
screens in five hospitals in one study (Vohr et al., 2001).
Vohr et al. reported the cost for providing an OAE screen
as $66.87. According to our analysis, an outpatient OAE
screen performed in a hospital setting was reimbursed
at a median rate of $116.90 and a mean of $155.98
for privately insured infants. The cost for providing an
ABR screen was reported as $95.04 (adjusted to 2014
dollars) by Vohr et al. and we found the median and mean
reimbursement rates for an automated ABR screen (CPT
92856) were $102.18 and $136.33 respectively.
This analysis has several limitations. First, billing codes
are subject to coding errors (O’Malley et al., 2005), which
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means that some claims for what appear to be NBHS may
actually be for a different service. Second, we examined
claims data from 2013 to 2015 for the 2013–2014
birth cohort using ICD-9-CM codes to avoid the coding
transition to ICD-10 on October 1, 2015. However, the
claims data are now more than 4 years old and may be
a bit dated. The estimates may have changed since the
study was completed in 2017. Finally, the data used in
this study comes from employer-based plans and cannot
be generalized to other types of private payers. The
MarketScan Commercial data have been found to be
comparable in demographics to the U.S. population with
employer-sponsored insurance (Aizcorbe et al., 2012),
which in turn comprises more than 90% of the U.S.
population with private insurance. However, MarketScan
data cannot be generalized to populations with public
insurance or no insurance.

Lin, H. C., Shu, M. T., Lee, K. S., Ho, G. M., Fu, T.
Y., Bruna, S., & Lin, G. (2005). Comparison of
hearing screening programs between one step with
transient evoked otoacoustic emissions (TEOAE)
and two steps with TEOAE and automated auditory
brainstem response. Laryngoscope, 115(11), 1957–
1962. doi:10.1097/01.mlg.0000178323.06183.3e
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